Telerehabilitation Improves QoL, Physical Functions and Compliance in Patients With COPD

June 9, 2022 updated by: Ching-Hsia Hung, National Cheng-Kung University Hospital

Personalized Video-delivered Telerehabilitation Improves QoL, Muscle Strengths, Cardiopulmonary Functions and Compliance in Patients With COPD

The video-delivered pulmonary rehabilitation(PR) program is more convenience for COPD patient to carry out home-based PR. Also, the intervention will improve cardiopulmonary functions, QoL, and physical activity.

Study Overview

Detailed Description

Background and Purpose: Chronic obstructive pulmonary disease (COPD) is the 3rd global cause of deaths. Pulmonary rehabilitation (PR) is the standard treatment for this disease. However, the dropout rate remains high (33-50%) because of traffic issues and patients' low mobility. Therefore, telerehabilitation seems to be a better way to deliver PR. Using videos to deliver PR is not only easy to manipulate on the cellphone or ipad, but also improve patients' attention and compliance. Thus, the aim of this study is to assess whether tailor-made PR video rehabilitation program improves patients' quality of life (QoL), muscle strengths, cardiopulmonary functions, and compliance.

Methods: This is a randomized controlled trial with 6-week follow-up. Participants were medically stable COPD patients and able to use LINE and YOUTUBE in cellphone. In the process of recruitment, they were all assessed by time-up-and-go test. The performance of time-up-and-go test should be lower than 12 seconds to rule out the participants with high risks of falling. They were randomly assigned to control group or intervention group to conduct 6-week home-based PR program. Patients in control group received the education booklet with words and pictures. Patients in intervention group watched YOUTUBE videos to rehab and recorded the intensity after the exercise by RPE scores. During the intervention, a physical therapist would have weekly telephone calls or LINE calls for 6 times to monitor and modify the intensity of exercise. The videos included 5-minute breathing reeducation, 20-minute interval strengthening exercise and 5-minute education animation. All patients were assessed the performance of spirometry, cardiopulmonary exercise test (CPET), questionnaires about symptoms, QoL, muscle strengths and distances of 6-minute walk test (6MWT) before intervention, after intervention and after 6-week follow-up.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tainan, Taiwan, 704
        • National Cheng Kung University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • COPD
  • Be medically stable
  • Ability to use a smartphone and applications (LINE and Youtube)
  • Access to the internet
  • Have visual and auditory impairments corrected with assistive devices

Exclusion Criteria:

  • Other respiratory disease as main complaint other than COPD
  • Exacerbations within 4 weeks
  • Had enrolled PR programs within the last 6 months
  • Unable to follow verbal instructions, suffer from cognitive impairment, or have language difficulties
  • Unstable medical conditions
  • Any comorbidities which precluded exercise training

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
SHAM_COMPARATOR: Control group
Patients in control group received the education booklet with words and pictures.
COPD patients conduct pulmonary rehabilitation for 6 weeks by read an education booklet with words and pictures which is made by the physiotherapist.
EXPERIMENTAL: Video group
Patients in intervention group watched YOUTUBE videos to rehab and recorded the intensity after the exercise by RPE scores. During the intervention, a physical therapist would have weekly telephone calls or LINE calls for 6 times to monitor and modify the intensity of exercise.
COPD patients conduct pulmonary rehabilitation for 6 weeks by watching Youtube videos which were made by the physiotherapist.The patients are monitored by the physiotherapist by weekly phone call and asked to record RPE scores at the RPE form.
EXPERIMENTAL: Booklet group
Patients in intervention group read education booklet with words and pictures to rehab and recorded the intensity after the exercise by RPE scores. During the intervention, a physical therapist would have weekly telephone calls or LINE calls for 6 times to monitor and modify the intensity of exercise.
COPD patients conduct pulmonary rehabilitation for 6 weeks by read an education booklet with words and pictures which is made by the physiotherapist.The patients are monitored by the physiotherapist by weekly phone call and asked to record RPE scores at the RPE form.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time point difference of AT from 1st week to 6th week
Time Frame: From 1st week to 6th week
Use cardiopulmonary exercise test (CPET) to get the change of time point difference of AT from 1st week(intervention starts) to 6th week(intervention ends)
From 1st week to 6th week
Time point difference of AT from 1st week to 12th week
Time Frame: From 1st week to 12th week
Use cardiopulmonary exercise test (CPET) to get the change of time point difference of AT from 1st week(intervention starts) to 12th week(follow up ends)
From 1st week to 12th week
Time point difference of AT from 6th week to 12th week
Time Frame: From 6th week to 12th week
Use cardiopulmonary exercise test (CPET) to get the change of time point of AT from 6th week(intervention ends) to 12th week(follow up ends)
From 6th week to 12th week
Change of maximal exercise work from 1st week to 6th week
Time Frame: From 1st week to 6th week
Use cardiopulmonary exercise test (CPET) to get the change of values of the pateint's total work (watt) from 1st week(intervention starts) to 6th week(intervention ends)
From 1st week to 6th week
Change of maximal exercise work from 1st week to 12th week
Time Frame: From 1st week to 12th week
Use cardiopulmonary exercise test (CPET) to get the change of values of the pateint's total work (watt) from 1st week(intervention starts) to to 12th week(follow up ends)
From 1st week to 12th week
Change of maximal exercise work from 6th week to 12th week
Time Frame: From 6th week to 12th week
Use cardiopulmonary exercise test (CPET) to get the change of values of the pateint's total work (watt) from 6th week(intervention ends) to 12th week(follow up ends)
From 6th week to 12th week
Change of VO2max from 1st week to 6th week
Time Frame: From 1st week to 6th week
Use cardiopulmonary exercise test (CPET) to get the change of values of VO2max (mL/min/kg) from 1st week(intervention starts) to 6th week(intervention ends)
From 1st week to 6th week
Change of VO2max from 1st week to 12th week
Time Frame: From 1st week to 12th week
Use cardiopulmonary exercise test (CPET) to get the change of values of VO2max (mL/min/kg) from 1st week(intervention starts) to 12th week(follow up ends)
From 1st week to 12th week
Change of VO2max from 6th week to 12th week
Time Frame: From 6th week to 12th week
Use cardiopulmonary exercise test (CPET) to get the change of values of VO2max (mL/min/kg) from 6th week(intervention ends) to 12th week(follow up ends)
From 6th week to 12th week
Change of VE/VCO2 from 1st week to 6th week
Time Frame: From 1st week to 6th week
Use cardiopulmonary exercise test (CPET) to get the change of values of VE/VCO2 from 1st week(intervention starts) to 6th week(intervention ends)
From 1st week to 6th week
Change of VE/VCO2 from 1st week to 12th week
Time Frame: From 1st week to 12th week
Use cardiopulmonary exercise test (CPET) to get the change of values of VE/VCO2 from 1st week(intervention starts) to 12th week(follow up ends)
From 1st week to 12th week
Change of VE/VCO2 from 6th week to 12th week
Time Frame: From 6th week to 12th week
Use cardiopulmonary exercise test (CPET) to get the change of values of VE/VCO2 from 6th week(intervention ends) to 12th week(follow up ends)
From 6th week to 12th week
Change of muscle strength from 1st week to 6th week
Time Frame: From 1st week to 6th week
Use dynamometer to measure the changes of muscle strength(kg) from 1st week(intervention starts) to 6th week(intervention ends), including bilateral handgrip, elbow flexors (biceps) and knee extensors (quadriceps) for 3 times separately.The patient need to increase the strength to the highest level in 6 seconds and rest for 30 seconds.The highest value will be divided by the patient's body weight (kg/kg)
From 1st week to 6th week
Change of muscle strength from 1st week to 12th week
Time Frame: From 1st week to 12th week
Use dynamometer to measure the changes of muscle strength(kg) from 1st week(intervention starts) to 12th week(follow up ends), including bilateral handgrip, elbow flexors (biceps) and knee extensors (quadriceps) for 3 times separately.The patient need to increase the strength to the highest level in 6 seconds and rest for 30 seconds.The highest value will be divided by the patient's body weight (kg/kg)
From 1st week to 12th week
Change of muscle strength from 6th week to 12th week
Time Frame: From 6th week to 12th week
Use dynamometer to measure the changes of muscle strength(kg) from 6th week(intervention ends) to 12th week(follow up ends), including bilateral handgrip, elbow flexors (biceps) and knee extensors (quadriceps) for 3 times separately.The patient need to increase the strength to the highest level in 6 seconds and rest for 30 seconds.The highest value will be divided by the patient's body weight (kg/kg)
From 6th week to 12th week
Change of 6-minute walk test from 1st week to 6th week
Time Frame: From 1st week to 6th week
Measure the change of 6-minute walk test from 1st(intervention starts) week to 6th week(intervention ends).The patient walks in his/her own pace, as far as he/she can in 6 minutes at the 20-meter long straight path and the we will record the distance in meter.Stop when time's up or patient develops clinical symptoms.
From 1st week to 6th week
Change of 6-minute walk test from 1st week to 12th week
Time Frame: From 1st week to 12th week
Measure the change of 6-minute walk test from 1st(intervention starts) week to 12th week(follow up ends).The patient walks in his/her own pace, as far as he/she can in 6 minutes at the 20-meter long straight path and the we will record the distance in meter.Stop when time's up or patient develops clinical symptoms.
From 1st week to 12th week
Change of 6-minute walk test from 6th week to 12th week
Time Frame: From 6th week to 12th week
Measure the change of 6-minute walk test from 6th(intervention ends) week to 12th week(follow up ends).The patient walks in his/her own pace, as far as he/she can in 6 minutes at the 20-meter long straight path and the we will record the distance in meter.Stop when time's up or patient develops clinical symptoms.
From 6th week to 12th week
Attendance rate in video group or booklet group
Time Frame: From 1st week to 6th week
If the patient completes 70% or more of the intervention program by being analyzed from the record of RPE form, he/she will be recognize as being completed the intervention.Finally, we will count the number of the patients who completed the intervention to be divided by the number of totally patients in video/booklet group at 6th week.
From 1st week to 6th week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
FEV1
Time Frame: Baseline, 6 weeks later, and 12 weeks later
Use spirometry to measure the values of FEV1 (%) for 3 times.The highest result will be recored.
Baseline, 6 weeks later, and 12 weeks later
FEV1/FVC
Time Frame: Baseline, 6 weeks later, and 12 weeks later
Use spirometry to measure the values of FEV1/FVC for 3 times.The highest result will be recored.
Baseline, 6 weeks later, and 12 weeks later
Modified Medical Research Council (mMRC)
Time Frame: Baseline, 6 weeks later, and 12 weeks later
Level of Modified Medical Research Council (mMRC)
Baseline, 6 weeks later, and 12 weeks later
COPD Assessment Test (CAT)
Time Frame: Baseline, 6 weeks later, and 12 weeks later
Total score of COPD Assessment Test (CAT)
Baseline, 6 weeks later, and 12 weeks later
EuroQol-5 Dimensions-5 Levels (EQ-5D-5L)
Time Frame: Baseline, 6 weeks later, and 12 weeks later
Score of EuroQol-5 Dimensions-5 Levels (EQ-5D-5L)
Baseline, 6 weeks later, and 12 weeks later
Clinical COPD Questionnaires (CCQ)
Time Frame: Baseline, 6 weeks later, and 12 weeks later
Score of Clinical COPD Questionnaires (CCQ)
Baseline, 6 weeks later, and 12 weeks later

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 2, 2020

Primary Completion (ACTUAL)

May 31, 2021

Study Completion (ACTUAL)

July 10, 2021

Study Registration Dates

First Submitted

April 14, 2021

First Submitted That Met QC Criteria

April 28, 2021

First Posted (ACTUAL)

May 3, 2021

Study Record Updates

Last Update Posted (ACTUAL)

June 10, 2022

Last Update Submitted That Met QC Criteria

June 9, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Telerehabilitation

Clinical Trials on Education

3
Subscribe